55bmw online casino real money

2 ASX 200 shares to buy that this fund manager is bullish aboutLA Galaxy wins record 6th MLS Cup

Prominent figure from Canada's trucker protests against COVID-19 restrictions found guiltyNoneRavens WR Zay Flowers (shoulder) questionable vs. Texans

Researchers from the RMIT University in Australia and Indian institutions unveiled a gold-based cancer drug with promising potential. The medication slowed tumor growth in animals by 82 percent. Even better, it targeted cancer cells more effectively than conventional chemotherapy agents. Distinguished Professor Suresh Bhargava AM, who led the project at RMIT, emphasized that this discovery could lead to safer and more effective cancer treatments. READ: Talc is ‘probably’ cancer-causing, says WHO agency The Royal Melbourne Institute of Technology (RMIT) explained that their revolutionary cancer drug contains a unique gold compound. It’s called Gold (I), which the researchers designed to be highly reactive and biologically active. Also, they tailored it to interact with a common cancer cell enzyme called thioredoxin reductase. READ: Seven-year-old girl with cancer under the care of Kapwa Ko Mahal Ko Foundation calls for help The gold compound blocks this protein, shutting down cancer cells before they can multiply or develop drug resistance. Bhargava said this highly targeted approach minimizes the toxic side effects seen in the chemotherapy drug cisplatin. “Their selectivity in targeting cancer cells, combined with reduced systemic toxicity...,” he said. “...points to a future where treatments are more effective and far less harmful,” the project lead added. Gold (I) is also more stable than those from earlier studies. Consequently, the cancer drug can remain intact while reaching the tumor site. Project co-lead at RMIT, Distinguished Professor Magdalena Plebanski, explained another reason why the golden treatment is effective. In zebrafish studies, it stopped the formation of new blood vessels that tumors need to grow. This effect is known as anti-angiogenesis, and this gold compound was the first with this property. As a result, these characteristics make it highly effective against various cancer cells. For example, it might treat ovarian cancer cells, which can develop cisplatin resistance. “Seeing our gold compound have such strong efficacy against tough-to-treat ovarian cancer cells is an important step toward addressing recurrent cancers and metastases,” stated Plebanski. However, Bhargava reiterated that “human trials are still a way off.” Nevertheless, he and the research team “are really encouraged by these results.” The cancer drug’s Gold (I) gained US Patent protection, preparing it for further development toward potential clinical applications.

NASSAU, Bahamas (AP) — Alyssa Ustby and Lexi Donarski scored 14 points apiece, and Ustby added 14 rebounds to lead No. 16 North Carolina to a 53-36 victory over Villanova in a semifinal game at the Women's Battle 4 Atlantis on Sunday. The Tar Heels (5-1) play Indiana in the championship game on Monday. The Hoosiers upset No. 18 Baylor 73-65 in Sunday's first semifinal. Ustby made 6 of 8 shots from the floor with a 3-pointer for North Carolina on the way to her first double-double of the season. Donarski hit 6 of 10 shots with a pair of 3-pointers. Maddie Webber led the Wildcats (4-2) with 12 points on 4-for-7 shooting from beyond the arc. Lara Edmanson pitched in with 11 points and seven rebounds. The Tar Heels held Villonova's leading scorer Jasmine Bascoe to two points after she came in averaging 16.6 per game. Bascoe missed all seven of her shots — three from distance — and made 2 of 4 at the free-throw line. Ustby had seven points and Donarski scored five to guide the Tar Heels to a 17-7 lead after one quarter. Donarski scored five more in the third quarter to help North Carolina turn a 30-18 lead at halftime into a 44-23 advantage heading to the final period. North Carolina shot 40% from the floor, made 5 of 17 from beyond the arc (29.4%) and 4 of 6 at the foul line. Villanova shot 23.5% overall but made 5 of 18 from distance (27.8%) and 7 of 10 free throws. The Tar Heels scored 15 points off of 21 Villanova turnovers. They turned it over 14 times but it led to only three points for the Wildcats. North Carolina outscored Villanova 30-14 in the paint and never trailed. ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP women’s college basketball: https://apnews.com/hub/ap-top-25-womens-college-basketball-poll and https://apnews.com/hub/womens-college-basketball